Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OcellO
Leiden, South Holland, Netherlandsocello.nl ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
OcellO specializes in advanced organotypic human tissue models and high-content 3D imaging to offer preclinical compound screening services focusing on cancer, inflammation, and polycystic kidney disease. Their technologies enable recapitulation of complex human biology for robust in vitro drug profiling.
- Therapeutic areas
- NephrologyOncologyImmunology
- Modalities
- Small moleculeMonoclonal antibodyBiologic
- Industry
- Drug Discovery Services
02
Partnerships
Merus
Beyond the preview
Go deeper on OcellO.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OcellO.